Does bloodwork actually matter on a testosterone cycle?

What did @jbayne7 actually say?

Honestly? Not much that can be evaluated. The transcript provided consists entirely of numbers, likely a rep count or a set log captured mid-workout. There are no verbal claims in the recorded audio beyond what appears to be counting during an exercise set. The caption, however, does make a real claim worth examining: "Bloodwork is an essential part of cycling."

We are treating that caption claim as the substantive assertion here, because it is the only coherent health-related statement attached to this content. The hashtags confirm the context: TRT, first cycle, PCT. This video is aimed at people starting or considering anabolic steroid use or testosterone replacement therapy, and it is telling them to monitor their bloodwork. That is a meaningful message, even if the spoken content did not deliver it.

Does the science back this up?

Yes, and strongly. This is one of the few pieces of advice in the performance-enhancement space that has broad clinical consensus behind it. Monitoring biomarkers during testosterone administration is not optional if you care about outcomes.

A 2010 paper by Basaria et al. in the New England Journal of Medicine, the Testosterone in Older Men with Mobility Limitations trial, was actually stopped early because the testosterone group showed a higher rate of cardiovascular adverse events. Hematocrit elevation was one of the mechanisms implicated. Hematocrit, hemoglobin, PSA in older men, liver enzymes, and lipid panels are all markers that shift meaningfully on exogenous testosterone. The Endocrine Society clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) explicitly recommend monitoring hematocrit at three to six months and then annually on TRT. For someone running a supraphysiological cycle rather than supervised TRT, the stakes are higher and the monitoring intervals arguably need to be tighter.

What did they get wrong (or right)?

Credit where it is due: the caption message is correct. Bloodwork monitoring during a cycle is not a nice-to-have. It is the difference between catching a hematocrit creeping toward 54 percent before it becomes a clot risk versus finding out after the fact.

What the video gets wrong is everything it does not say. There is no guidance on what panels to run, when to run them, or what to do with the results. Telling someone to "never neglect your bloodwork" without specifying which markers to check is like telling a new driver to "pay attention to the car" without mentioning the fuel gauge or temperature warning. A pre-cycle baseline is necessary. Mid-cycle checks for hematocrit, estradiol, and lipids matter. Post-PCT confirmation that natural testosterone production has recovered is a separate and often skipped step. None of that context exists in this video. For a first-cycle audience, that gap is a real problem.

What should you actually know?

If you are on TRT through a licensed provider, your monitoring schedule should be driven by your prescribing clinician, not by TikTok. The Endocrine Society guidelines recommend a testosterone level check at one to two months after starting or adjusting a dose, hematocrit at three to six months, and lipid panels within the first year.

For people using anabolic steroids outside a medical context, the risks compound. Supraphysiological testosterone levels suppress HDL cholesterol significantly, as documented by Palatini et al. (1996, International Journal of Sports Medicine) and confirmed repeatedly since. Liver strain, particularly with oral androgens, requires ALT and AST monitoring. Estradiol elevation drives water retention and gynecomastia risk. And hematocrit above 54 percent is a recognized threshold where therapeutic phlebotomy is considered, per the American Urological Association guidelines (Mulhall et al., 2018).

The bottom line: the caption claim is accurate. Bloodwork matters. But a six-word caption aimed at a first-cycle audience needs far more scaffolding to be genuinely useful rather than just technically correct.